目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Application
2.2.2 Region
2.3 Competitive Insights

Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.1.2.1 Facial injectable market
3.1.2.2 Knee replacement/implants market
3.2 User Perspective Analysis
3.2.1 Consumer Behavior Analysis
3.2.2 Market Influencer Analysis
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Increasing Geriatric Population
3.3.1.2 Growing Awareness For Antiaging Products
3.3.1.3 High Prevalence Of Target Diseases
3.3.2 Market Restraint Analysis
3.3.2.1 Associated adverse effects of hyaluronic acid
3.3.2.2 High cost of products and related services
3.4 Business Environment Analysis Tools
3.4.1 Pestle Analysis
3.4.1.1 Political & legal landscape
3.4.1.2 Economic & social landscape
3.4.1.3 Technological landscape
3.4.2 Porter’s Five Forces Analysis
3.4.2.1 Competitive rivalry
3.4.2.2 Bargaining power of suppliers
3.4.2.3 Bargaining power of buyers
3.4.2.4 Threat of new entrants
3.4.2.5 Threat of substitutes
3.5 Penetration & Growth Prospect Mapping
3.6 Major Deals & Strategic Alliances Analysis
3.6.1.1 Licensing & partnerships, technology collaborations
3.6.1.2 Mergers & Acquisitions
3.7 Impact of COVID-19: Qualitative Analysis

Chapter 4 Hyaluronic Acid Market: Application Analysis
4.1 Hyaluronic Acid Market Share Analysis, 2021 & 2030
4.2 Segment Dashboard
4.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the Application
4.3.1 Osteoarthritis
4.3.1.1 Osteoarthritis Market, 2017 - 2030 (USD Million)
4.3.1.2 Three Injection
4.3.1.2.1 Three Injection Market, 2017 - 2030 (USD Million)
4.3.1.3 Single Injection
4.3.1.3.1 Single-Injection Market, 2017 - 2030 (USD Million)
4.3.1.4 Five Injection
4.3.1.4.1 Five Injection Market, 2017 - 2030 (USD Million)
4.3.2 Dermal Fillers
4.3.2.1 Dermal Fillers Market, 2017 - 2030 (USD Million)
4.3.3 Ophthalmic
4.3.3.1 Ophthalmic Market, 2017 - 2030 (USD Million)
4.3.4 Vesicoureteral Reflux
4.3.4.1 Vesicoureteral Reflux Market, 2017 - 2030 (USD Million)

Chapter 5 Hyaluronic Acid Market: Regional Analysis
5.1 Regional Market Share Analysis, 2021 & 2030
5.2 Regional Market Snapshot
5.3 Market Size & Forecasts and Trend Analysis, 2021 to 2030
5.3.1 North America
5.3.1.1 North America Hyaluronic Acid market, 2017 - 2030 (USD Million)
5.3.1.2 U.S.
5.3.1.2.1 U.S. Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.1.3 Canada
5.3.1.3.1 Canada Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.2 Europe
5.3.2.1 Europe Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.2.2 Germany
5.3.2.2.1 Germany Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.2.3 France
5.3.2.3.1 France Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.2.4 Spain
5.3.2.4.1 Spain Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.2.5 U.K.
5.3.2.5.1 U.K. Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.2.6 Italy
5.3.2.6.1 Italy Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.3 Asia Pacific
5.3.3.1 Asia Pacific Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.3.2 Japan
5.3.3.2.1 Japan Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.3.3 China
5.3.3.3.1 China Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.3.4 India
5.3.3.4.1 India Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.3.5 Australia
5.3.3.5.1 Australia Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.3.6 South Korea
5.3.3.6.1 South Korea Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.4 Latin America
5.3.4.1 Latin America Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.4.2 Brazil
5.3.4.2.1 Brazil Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.4.3 Mexico
5.3.4.3.1 Mexico Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.4.4 Argentina
5.3.4.4.1 Argentina Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.5 Middle East & Africa
5.3.5.1 MEA Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.5.2 South Africa
5.3.5.2.1 South Africa Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.5.3 Saudi Arabia
5.3.5.3.1 Saudi Arabia Hyaluronic Acid Market, 2017 - 2030 (USD Million)
5.3.5.4 UAE
5.3.5.4.1 UAE Hyaluronic Acid Market, 2017 - 2030 (USD Million)

Chapter 6 Reimbursement Outlook
6.1 Reimbursement by Product
6.1.1 Gel-One
6.1.2 Euflexxa
6.1.3 Synvisc-One
6.1.4 Supartz
6.1.5 Hyalgan
6.1.6 Monovisc
6.1.7 Orthovisc
6.1.8 Others
6.2 Reimbursement By Region
6.2.1 U.S.
6.2.2 Canada
6.2.3 China
6.2.4 Japan
6.2.5 India
6.2.6 Brazil
6.2.7 South Africa
6.2.8 Europe
6.2.8.1 U.K.
6.2.8.2 Germany
6.2.8.3 France
6.2.8.4 Italy
6.2.8.5 Spain

Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.2 Competition Categorization
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 Strategy Mapping
7.3.2.1 Launch of new products
7.3.2.2 Geographical expansion
7.3.2.3 Marketing & promotions
7.4 Company Market Position Analysis
7.4.1 Company Market Position Analysis
7.5 Company Profiles
7.5.1 ALLERGAN
7.5.1.1 Company overview
7.5.1.2 Financial performance
7.5.1.3 Product benchmarking
7.5.1.4 Strategic initiatives
7.5.1.5 SWOT analysis
7.5.2 SANOFI
7.5.2.1 Company overview
7.5.2.2 Financial performance
7.5.2.3 Product benchmarking
7.5.2.4 Strategic initiatives
7.5.2.5 SWOT analysis
7.5.3 GENZYME CORPORATION
7.5.3.1 Company overview
7.5.3.2 Product benchmarking
7.5.4 ANIKA THERAPEUTICS, INC.
7.5.4.1 Company overview
7.5.4.2 Financial performance
7.5.4.3 Product benchmarking
7.5.4.4 Strategic initiatives
7.5.4.5 SWOT analysis
7.5.5 SALIX PHARMACUETICALS
7.5.5.1 Company overview
7.5.5.2 Financial performance
7.5.5.3 Product benchmarking
7.5.5.4 Strategic initiatives
7.5.5.5 SWOT analysis
7.5.6 SEIKAGAKU CORPORATION
7.5.6.1 Company overview
7.5.6.2 Financial performance
7.5.6.3 Product benchmarking
7.5.6.4 Strategic initiatives
7.5.6.5 SWOT analysis
7.5.7 F. HOFFMANN-LA ROCHE AG
7.5.7.1 Company overview
7.5.7.2 Financial performance
7.5.7.5 Product benchmarking
7.5.7.4 SWOT analysis
7.5.8 GALDERMA LABORATORIES L.P.
7.5.8.1 Company overview
7.5.8.2 Financial performance
7.5.8.3 Product benchmarking
7.5.8.4 Strategic initiatives
7.5.8.5 SWOT analysis
7.5.9 ZIMMER BIOMET
7.5.9.1 Company overview
7.5.9.2 Financial performance
7.5.9.3 Product benchmarking
7.5.9.4 Strategic initiatives
7.5.9.5 SWOT analysis
7.5.10 SMITH & NEPHEW PLC
7.5.10.1 Company overview
7.5.10.2 Financial performance
7.5.10.3 Product benchmarking
7.5.10.4 Strategic initiatives
7.5.10.5 SWOT analysis
7.5.11 FERRING B.V
7.5.11.1 Company overview
7.5.11.2 Financial performance
7.5.11.3 Product benchmarking
7.5.11.4 Strategic initiatives
7.5.12 LIFECORE BIOMEDICAL, LLC
7.5.12.1 Company overview
7.5.12.2 Financial performance
7.5.12.3 Product benchmarking
7.5.12.4 Strategic initiatives
7.5.12.5 SWOT analysis
7.5.13 HTL BIOTECHNOLOGY
7.5.13.1 Company overview
7.5.13.2 Financial performance
7.5.13.3 Product benchmarking
7.5.13.4 Strategic initiatives
7.5.14 SHISEIDO COMPANY, LIMITED
7.5.14.1 Company overview
7.5.14.2 Financial performance
7.5.14.3 Product benchmarking
7.5.14.4 Strategic initiatives
7.5.14.5 SWOT analysis
7.5.15 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED
7.5.15.1 Company overview
7.5.15.2 Financial Performance
7.5.15.3 Product benchmarking
7.5.15.4 Strategic initiatives
7.5.15.5 SWOT analysis
7.5.16 LG LIFE SCIENCES LTD (LG CHEM.)
7.5.16.1 Company overview
7.5.16.2 Financial Performance
7.5.16.3 Product benchmarking
7.5.16.4 Strategic initiatives
7.5.16.5 SWOT analysis
7.5.17 MARUHA NICHIRO, INC.
7.5.17.1 Company overview
7.5.17.2 Financial performance
7.3.17.5 Product benchmarking
7.5.17.4 Strategic initiatives
7.5.17.5 SWOT analysis

List of Tables
Table 1 North America hyaluronic acid market, by country, 2017 - 2030 (USD Million)
Table 2 North America hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 3 U.S. hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 4 Canada hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 5 Europe hyaluronic acid market, by country, 2017 - 2030 (USD Million)
Table 6 Europe hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 7 U.K. hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 8 Germany hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 9 France hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 10 Italy hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 11 Spain hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 12 Asia Pacific hyaluronic acid market, by country, 2017 - 2030 (USD Million)
Table 13 Asia Pacific hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 14 Japan hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 15 China hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 16 India hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 17 Australia hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 18 South Korea hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 19 Latin America hyaluronic acid market, by country, 2017 - 2030 (USD Million)
Table 20 Latin America hyaluronic acid market by application, 2017 - 2030 (USD Million)
Table 21 Brazil hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 22 Mexico hyaluronic acid market by application, 2017 - 2030 (USD Million)
Table 23 Argentina hyaluronic acid market by application, 2017 - 2030 (USD Million)
Table 24 MEA hyaluronic acid market, by country, 2017 - 2030 (USD Million)
Table 25 MEA hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 26 South Africa hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 27 Saudi Arabia hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 28 UAE hyaluronic acid market, by application, 2017 - 2030 (USD Million)
Table 29 List of secondary sources
Table 30 List of abbreviations
Table 31 Cost of viscos supplements - U.S.
Table 32 NYS non-coverage details
Table 33 HCPCS Code
Table 34 Labelling instructions by the FDA
Table 35 Distribution and marketing rights of Synvisc

List of Figures
Fig. 1 Hyaluronic acid market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook, 2021 (USD Million)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Ratio of adult population to total population (billion)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Hyaluronic acid market: Application movement analysis (USD Million)
Fig. 16 Hyaluronic acid application outlook: Key takeaways (USD Million)
Fig. 17 Osteoarthritis market, 2017 - 2030 (USD Million)
Fig. 18 Three injection market, 2017 - 2030 (USD Million)
Fig. 19 Single injection market, 2017 - 2030 (USD Million)
Fig. 20 Five injection market, 2017 - 2030 (USD Million)
Fig. 21 Dermal fillers market, 2017 - 2030 (USD Million)
Fig. 22 Ophthalmic market, 2017 - 2030 (USD Million)
Fig. 23 Vesicoureteral reflux market, 2017 - 2030 (USD Million)
Fig. 24 Regional outlook, 2021 & 2030
Fig. 25 Regional marketplace: Key takeaways
Fig. 26 North America hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 27 U.S. hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 28 Canada hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 29 Europe hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 30 Germany hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 31 France hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 32 Spain hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 33 U.K. hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 34 Italy hyaluronic acid market, 2017 - 2030 (USD million)
Fig. 35 Asia Pacific hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 36 Japan hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 37 China hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 38 India hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 39 Australia hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 40 South Korea hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 41 Latin America hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 42 Brazil hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 43 Mexico hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 44 Argentina hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 45 MEA hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 46 South Africa hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 47 Saudi Arabia hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 48 UAE hyaluronic acid market, 2017 - 2030 (USD Million)
Fig. 49 Recent development & impact analysis by key market participants
Fig. 50 Competition categorization
Fig. 51 Market position analysis